Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Montgomery

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
CNS Spectrums|February 10, 2004
WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adultsJohn H Greist, Borwin Bandelow, Eric Hollander, et al.
CNS Spectrums|February 10, 2004
WCA recommendations for the long-term treatment of generalized anxiety disorderChrister Allgulander, Borwin Bandelow, Eric Hollander, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 12, 2010
Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorderSiegfried Kasper, Stuart A Montgomery, Hans-Jürgen Möller, et al.
Journal of Clinical Psychopharmacology|January 16, 2010
Desvenlafaxine for the prevention of relapse in major depressive disorder: results of a randomized trialKarl Rickels, Stuart A Montgomery, Karen A Tourian, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 4, 2006
Duloxetine in the prevention of relapse of major depressive disorder: double-blind placebo-controlled studyDavid G Perahia, Inmaculada Gilaberte, Fujun Wang, et al.
The International Journal of Neuroscience|June 24, 2014
Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depressionLaura Carlberg, Alexandra Schosser, Raffaella Calati, et al.
CNS Spectrums|February 10, 2004
WCA recommendations for the long-term treatment of social phobiaMichael Van Ameringen, Christer Allgulander, Borwin Bandelow, et al.
The Journal of Clinical Psychiatry|August 29, 2002
Selecting methodologies for the evaluation of differences in time to response between antidepressantsStuart A Montgomery, Per Bech, Pierre Blier, et al.
International Clinical Psychopharmacology|October 6, 2007
Which antidepressants have demonstrated superior efficacy? A review of the evidenceStuart A Montgomery, David S Baldwin, Pierre Blier, et al.
The Journal of Clinical Psychiatry|October 5, 2002
Partial response and nonresponse to antidepressant therapy: current approaches and treatment optionsRobert M A Hirschfeld, Stuart A Montgomery, Eugenio Aguglia, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
CNS Spectrums|February 10, 2004
WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adultsJohn H Greist, Borwin Bandelow, Eric Hollander, et al.
CNS Spectrums|February 10, 2004
WCA recommendations for the long-term treatment of generalized anxiety disorderChrister Allgulander, Borwin Bandelow, Eric Hollander, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 12, 2010
Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorderSiegfried Kasper, Stuart A Montgomery, Hans-Jürgen Möller, et al.
Journal of Clinical Psychopharmacology|January 16, 2010
Desvenlafaxine for the prevention of relapse in major depressive disorder: results of a randomized trialKarl Rickels, Stuart A Montgomery, Karen A Tourian, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 4, 2006
Duloxetine in the prevention of relapse of major depressive disorder: double-blind placebo-controlled studyDavid G Perahia, Inmaculada Gilaberte, Fujun Wang, et al.
The International Journal of Neuroscience|June 24, 2014
Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depressionLaura Carlberg, Alexandra Schosser, Raffaella Calati, et al.
CNS Spectrums|February 10, 2004
WCA recommendations for the long-term treatment of social phobiaMichael Van Ameringen, Christer Allgulander, Borwin Bandelow, et al.
The Journal of Clinical Psychiatry|August 29, 2002
Selecting methodologies for the evaluation of differences in time to response between antidepressantsStuart A Montgomery, Per Bech, Pierre Blier, et al.
International Clinical Psychopharmacology|October 6, 2007
Which antidepressants have demonstrated superior efficacy? A review of the evidenceStuart A Montgomery, David S Baldwin, Pierre Blier, et al.
The Journal of Clinical Psychiatry|October 5, 2002
Partial response and nonresponse to antidepressant therapy: current approaches and treatment optionsRobert M A Hirschfeld, Stuart A Montgomery, Eugenio Aguglia, et al.
Pageof 5